February 2026 Research Update

This month, the clearest human data focused on low blood sugar in Kabuki syndrome, suggesting it may be more common than many families expect in some genetic subtypes. In a small single-center group, congenital hyperinsulinism (when the pancreas releases too much insulin) accounted for a meaningful share of neonatal low blood sugar and sometimes persisted beyond the newborn period. The same report also suggested a pattern: persistent or recurrent low blood sugar clustered in people with truncating KMT2D gene changes, while it was not seen in those with missense changes in that cohort. [1]

In the patients whose congenital hyperinsulinism continued, the report described use of diazoxide, and one patient also needed octreotide, with the persistent cases responding to diazoxide in that center's experience. Because the study was retrospective and not everyone was systematically screened, it cannot tell exactly how common this problem is across all Kabuki syndrome families. Even so, it helps sharpen the picture that low blood sugar can be an important, treatable part of Kabuki syndrome for some people, and that the risk may vary by the exact type and location of the KMT2D change. [1]

For patients and caregivers, this adds a clearer explanation for why some children with Kabuki syndrome experience low blood sugar early in life, and why it may be persistent in a smaller group. The findings may matter now mainly as awareness and understanding, especially for families dealing with feeding issues, sleepiness, or other symptoms that can overlap with low blood sugar, but this report does not define how often to test or who should be tested. What remains uncertain is how well this genetic pattern holds in larger and more diverse groups, because the evidence comes from a small, single-center review without uniform screening. [1]

Several reports this month reinforced a practical point: Kabuki syndrome can appear in the workup for other birth differences, and broader genetic testing can sometimes uncover KMT2D changes when the clinical picture overlaps with other conditions. In groups evaluated for congenital vertebral malformations or for syndromic differences of sex development, genetic testing identified a KMT2D variant in a minority of patients, alongside other gene findings. This supports the idea that Kabuki syndrome is part of a wider set of developmental conditions that can share physical features, which can make gene-based diagnosis helpful. [2] [3]

In a Polish cohort of 34 people with vertebral malformations, a stepwise genetic approach found a molecular diagnosis in 4 people, including one with a KMT2D variant. The authors also reported that whole-exome sequencing was the most effective step in that workflow for finding answers in this group, although most patients still did not receive a genetic diagnosis. This matters because it shows both the potential and the limits of genetic testing when the starting point is a skeletal finding rather than a known syndrome. [2]

In a small Moroccan case series of 3 children with syndromic 46,XY differences of sex development, whole-exome sequencing found pathogenic variants in epigenetic genes, including a de novo KMT2D variant in one child diagnosed with Kabuki syndrome. The series highlights how genetic testing can help separate conditions that look similar early on, even when the initial concern is not Kabuki syndrome itself. Because it is only 3 patients, it mainly adds illustrative examples rather than firm estimates of how often this happens. [3]

For families, this theme mainly adds context about diagnosis: Kabuki syndrome may be recognized during evaluations for spine differences or differences in sex development, and broader genetic testing can sometimes clarify the underlying cause. This is most relevant when a child has features that do not fit neatly into one condition, since gene results may help explain why multiple body systems are involved. What remains uncertain is how often these approaches will find an answer for any given person, because the reported diagnostic yields were modest and the studies were small. [2] [3]

This month also included individual reports that broaden the list of medical issues that can occur alongside Kabuki syndrome, without showing how common they are. One report described Kabuki syndrome occurring with a congenital lung airway malformation found on chest CT, alongside developmental delays and a newly identified KMT2D missense change. Another report described a child with Kabuki syndrome who had complex aortic disease that was treated surgically with a good short-term recovery in that single patient. [4] [5]

These case reports are most useful as reminders of the wide range of body systems that can be involved in Kabuki syndrome, and how symptoms can lead to targeted imaging that identifies an additional condition. They also show that serious heart and vessel problems, while not described here as typical, can be part of an individual person's story and may involve specialized procedures and follow-up imaging. Because each report is a single patient, they cannot be used to estimate risk or to predict what will happen for others. [4] [5]

For patients and caregivers, these reports may matter now mainly as awareness that unusual findings can occur and may be investigated with imaging when symptoms point in that direction. They do not change what is known to be typical for Kabuki syndrome, and they do not indicate that most people with Kabuki syndrome will develop these problems. What they add is a clearer sense of the range of possible complications that have been documented, and the reminder that individual experiences can differ widely even with the same overall diagnosis. [4] [5]